Excelsyn shows sales growth in spite of recession

Published: 19-Oct-2009
Ingredients

UK-based pharma and biotech services group Excelsyn reported sales of


UK-based pharma and biotech services group Excelsyn reported sales of £11.7m and EBITDA of £2m, a 17% increase, for the financial year ended on 31 May 2009.

Sales rose by 16%, with EBITDA 108% higher than the previous year. The figures reflect three years of solid growth for the company, which has synthesis facilities in Holywell, North Wales. Chief executive Ian Shott says sales could reach £40m by 2014 and an acquisition is on the cards.

"We are poised to leverage some of the stuff we do to create a bigger group," he said at CPHi in Madrid.

In spite of the recession and suffering customer destocking of £3-4m during 2009, Shott says the company offers customers "agility and responsiveness" and the outlook looks good.

He added that Excelsyn is seeking partners. "We have a large patent portfolio and we need to exploit this."

Excelsyn was created in 2004 following Shott's acquisition of the former Great Lakes intermediates facility at Holywell. The company offers full custom synthesis services and small-volume commercial scale API production. It was awarded a Queen's Award for Enterprise 2009 in the international trade category. Overseas business accounts for 82% of sales.

See more

You may also like

Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

Read more
The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs

Trending Articles

  1. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
  2. Rousselot Rousselot is a global leader of gelatin and collagen-based solutions, serving the food, health & nutrition, biomedical, and pharmaceutical sectors. With our advanced Science & Innovation team, we unlock the secrets of the collagen molecule to create products that meet the highest standards of safety and quality. Through our state-of-the-art operations and extensive technical and formulation expertise, we help our customers achieve their goals, create world-class products, and we “Reach further together”. Rousselot is Darling’s Ingredients Health Brand.
  3. Debunking the myths of HPMC adoption Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
  4. Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
  5. Evonik increases plant-derived cholesterol supply The ingredient is used in the manufacture of mRNA vaccines and gene therapies

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
Ingredients

Debunking the myths of HPMC adoption

Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
Ingredients

Meet Navetta: new approach to safety testing of drugs and particles

Turn inhalation research upside down
Ingredients

Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer

Next-generation model offers ultra-fast scans and versatile measurement modes
Ingredients

IMCD bolsters API portfolio with Trichem Healthcare acquisition

This acquisition will bolster IMCD's portfolio of specialty pharmaceutical ingredients
Ingredients

BASF opens US GMP Solution Centre in Michigan

Catered towards its biopharma and small molecule customers, the site will provide excipients and bioprocessing ingredients to the US market
Subscribe now